|
Athabaskan brainstem dysgenesis
|
C535397 |
|
|
panenza vaccine
|
C560398 |
|
|
4-(4-ethylamino-(4-(N-ethylamino)-4'-(dimethylamino)stilbene))-1,4,7,10-tetraazacyclotridecane-11,13-dione
|
C560399 |
|
|
Charcot-Marie-Tooth disease, dominant intermediate 1
|
C535399 |
|
|
Aspergillus niger infection
|
C535390 |
|
|
Asrar Facharzt Haque syndrome
|
C535391 |
|
|
Metabolic Detoxication, Phase I
|
D050216 |
[Functionalization of exogenous substances to prepare them for conjugation in PHASE II DETOXIFICATION. Phase I enzymes include CYTOCHROME P450 enzymes and some OXIDOREDUCTASES. Excess induction of phase I over phase II detoxification leads to higher levels of FREE RADICALS that can induce CANCER and other cell damage. Induction or antagonism of phase I detoxication is the basis of a number of DRUG INTERACTIONS.
] |
|
Metabolic Detoxication, Phase II
|
D050217 |
[The conjugation of exogenous substances with various hydrophilic substituents to form water soluble products that are excretable in URINE. Phase II modifications include GLUTATHIONE conjugation; ACYLATION; and AMINATION. Phase II enzymes include GLUTATHIONE TRANSFERASE and GLUCURONOSYLTRANSFERASE. In a sense these reactions detoxify phase I reaction products.
] |
|
Body Fat Distribution
|
D050218 |
[Deposits of ADIPOSE TISSUE throughout the body. The pattern of fat deposits in the body regions is an indicator of health status. Excess ABDOMINAL FAT increases health risks more than excess fat around the hips or thighs, therefore, WAIST-HIP RATIO is often used to determine health risks.
] |
|
Amblyospora
|
D050219 |
[A genus of FUNGI, in the family Amblyosporidae, which is a parasite of MOSQUITOES.
] |
|
Sports for Persons with Disabilities
|
D064846 |
[Activities or games played by PERSONS WITH DISABILITIES, usually requiring physical effort or skill. The activities or games may be specifically created or based on existing sports, with or without modifications, to meet the needs of persons with physical or intellectual disabilities.
] |
|
Multimodal Imaging
|
D064847 |
[The use of combination of imaging techniques or platforms (e.g., MRI SCAN and PET SCAN) encompassing aspects of anatomical, functional, or molecular imaging methods.
] |
|
Mycelium
|
D025282 |
[The body of a fungus which is made up of HYPHAE.
] |
|
((17-N-cyclobutylmethyl)morphinan-3-yl-(-14-hydroxyl-17-N-cyclobutylmethyl) morphinan-3-yl) decanedioate
|
C560330 |
|
|
N-((E)-hex-2-enyl)phthalimide
|
C560331 |
|
|
nicotinic receptor alpha3beta4
|
C403530 |
|
|
1-((2S)-1-(4-(methoxycarbonyl)benzyl)-5-oxotetrahydro-1H-pyrrol-2-ylmethyl)-1H-imidazole-5-carboxylic acid
|
C560332 |
|
|
nicotinic receptor alpha4beta2
|
C403531 |
|
|
4-((2S)-2-(1H-imidazol-1-ylmethyl)-5-oxotetrahydro-1H-pyrrol-1-yl)methylbenzenecarboxylic acid
|
C560333 |
|
|
4-methyl-4-(octadecyloxycarbonylamino)heptanedioic acid
|
C560334 |
|
